Mahana IBS App Review (2026): Honest Take From a Gut-Directed Hypnotherapist

What is Mahana, and how is it different from Nerva?

Mahana is a prescription digital therapeutic for IBS, originally developed at Mahana Therapeutics, FDA-cleared in the US for the treatment of irritable bowel syndrome. The program runs roughly 3 months and is delivered self-guided through an app on your phone. The core mechanism is cognitive behavioural therapy adapted specifically for IBS, sometimes called CBT-for-IBS. That is the foundational distinction from Nerva, which delivers gut-directed hypnotherapy. Both are evidence-based. They are not the same thing.

CBT-for-IBS targets the cognitions, behaviours, and avoidance patterns that maintain IBS symptoms and disability. The Mahana program walks you through structured exercises, thought records, behavioural experiments, and graded exposure work, all delivered through the app interface. The pedigree is the Everitt 2019 ACTIB trial in Gut, which showed therapist-supported CBT-for-IBS produced durable symptom improvement at 12 and 24 months. Mahana takes that protocol and digitizes it.

Gut-directed hypnotherapy, which is what Nerva delivers and what I deliver clinically, works on a different mechanism. The Manchester Protocol and North Carolina Protocol use guided imagery and hypnotic suggestion targeted at the gut-brain axis, with the evidence base anchored by Peters et al's 2016 RCT in Aliment Pharmacol Ther showing gut-directed hypnotherapy was as effective as the low FODMAP diet for IBS. Different mechanism, different feel during sessions, comparable evidence base for response rates in clinical trials.

If you are choosing between Mahana and Nerva, you are largely choosing between CBT-for-IBS and gut-directed hypnotherapy as your primary nervous-system intervention. Some people respond better to one than the other. There is no reliable predictor for which one will fit you better in advance, which is part of why both have a place. The other major axis is regulatory pathway: Mahana is prescription-only and FDA-cleared, Nerva is direct-to-consumer with no prescription required. For a Canadian in 2026, that regulatory axis matters more in practice than the mechanism difference.

Does Mahana actually work? What the research says

Mahana's evidence base is real, and it is worth being specific about what it covers and what it does not.

The foundational study. Everitt and team published the ACTIB trial in Gut in 2019. ACTIB was a UK-based randomized controlled trial comparing therapist-supported CBT-for-IBS (delivered through a digital platform with a therapist available) and therapist-supported telephone CBT against treatment as usual. Both CBT arms outperformed treatment as usual at 12 months. The therapist-supported web-based arm reported around 61% of participants experiencing symptom relief at 12 months. The follow-up paper at 24 months showed the effect held up, which is a meaningful claim in a condition where most interventions fade.

Mahana's clearance. The FDA cleared Mahana's IBS product under the digital therapeutic pathway, which means the agency reviewed the clinical evidence and the software quality system and decided it met the bar for marketing as a treatment for IBS. FDA clearance is not the same as FDA approval, and it is not a guarantee that any individual user will respond. It does mean the product cleared a meaningful regulatory bar that, for example, a meditation app cannot clear.

The honest caveat on app delivery. The ACTIB trial that Mahana cites used therapist support alongside the digital platform. Mahana's commercial product is self-guided through the app. There is a real question, not unique to Mahana, about whether self-guided digital CBT produces the same effect size as therapist-supported digital CBT. The general answer in the broader CBT literature is that self-guided versions produce smaller effects, with completion rates being the main driver of the gap. Mahana has its own published data that I treat with appropriate skepticism since it comes from the company itself.

What Mahana does not claim, and you should not assume. It does not treat structural disease (IBD, celiac, microscopic colitis, motility disorders). It does not replace a workup for red-flag symptoms. It does not produce results in everyone, and the published response rates are not 100%, they are roughly in the 50% to 65% range depending on the outcome measure. That is the same general range as gut-directed hypnotherapy and as therapist-delivered CBT-for-IBS. There is no magic product in this category, only different mechanisms that work for different fractions of people.

How much does Mahana cost in Canada? (And can you even get it?)

This is the section where Mahana's story gets practically difficult for most Canadian readers. I am going to be direct about it because pretending otherwise wastes your time.

Pricing in the US. Mahana's retail US pricing varies by region, prescription pathway, and whether your insurance covers it. Out-of-pocket pricing has been reported in the rough range of $90 USD per month at various points, with the full 3-month program landing in the $250 to $350 USD ballpark when paid directly. Insurance coverage, when it applies, can reduce that substantially. Pricing pages and access pathways change, so verify directly through Mahana before assuming any specific number.

Access in Canada in 2026. Mahana is a US-FDA-cleared prescription digital therapeutic. It is not, as of 2026, a Health Canada licensed product at retail. The practical pathways for a Canadian to get it are limited: travel-related US prescriber relationships, US-based telehealth that will prescribe across borders (legally complicated), or self-importing through a friend or family member with US access. None of these are clean retail experiences. None of them produce a reliable, repeatable Canadian patient journey. If a Canadian reader emails me asking how to get Mahana, my honest answer is usually that the friction is high enough that one of the actually-available Canadian options is probably a better starting point.

What is actually available to Canadians at the app tier. Nerva, at $199 CAD per year, is the direct-to-consumer gut-directed hypnotherapy app available without a prescription anywhere in Canada. Calm Gut is a newer entrant, $80 to $150 CAD per year. Regulora is another FDA-cleared prescription digital therapeutic (gut-directed hypnotherapy mechanism), and like Mahana, it is not retail-available in Canada in 2026. The honest landscape for a Canadian reader is that Nerva is the realistic app-tier option, full stop.

What is available to Canadians at the clinician tier. ARCH-credentialed gut-specialized clinicians, including Calgary Gut Hypnotherapy, charge $220 to $350 per session depending on complexity. ARCH (Association of Registered Clinical Hypnotherapists of Canada) is Canada's most stringent voluntary professional body for clinical hypnotherapy. A 3-session commitment runs $660 to $1,050. A full 6 to 8 session protocol runs $1,320 to $2,800. Personalized, accountable, with the option of GP and gastroenterologist coordination that an app cannot offer.

If you are Canadian, weighing Mahana against the realistically available options means comparing a product you mostly cannot get against products you can. That is the practical frame.

Who is Mahana a good fit for?

Setting aside the access issue for a moment, the question of who Mahana actually fits well is worth answering on its own terms, because some readers will have US-side options and some Canadian readers may have a physician-supported pathway.

Mahana is a genuinely good fit if: You are based in the US, your physician will prescribe it, and your insurance picks up part of the cost. You prefer CBT as a mechanism, either because you have responded to CBT before in other contexts (anxiety, depression, insomnia) or because guided imagery and hypnosis feel uncomfortable to you. Your IBS is mild to moderate, you have already had structural disease ruled out, and you are looking for a structured nervous-system intervention you can do on your phone. You are self-directed and confident you will actually complete the 3-month program (this matters more than people realize).

Mahana is a reasonable fit if: You have already tried gut-directed hypnotherapy through an app or a clinician and did not respond, and you want to try the CBT mechanism instead. Mechanism switching is a legitimate strategy in this category, since not everyone responds to the same intervention, and trying both before concluding you are a non-responder to nervous-system work is reasonable. The Everitt 2019 trial gives the CBT mechanism a real evidence base that is comparable to the Peters 2016 hypnotherapy evidence base.

Mahana fits less well if: You are Canadian without a US-side access pathway. The friction is high enough that one of the actually-available options is probably better. You have complex overlap (active SIBO, functional dyspepsia alongside IBS, post-infectious IBS with a clear precipitant, IBD in remission). Apps in general, including Mahana, do not flex the protocol session by session, and a clinician usually serves the complex picture better. You have already failed two or three self-guided digital interventions for IBS or anxiety, which is a strong signal that you specifically need the human-in-the-loop element to actually finish.

A note on prescription pathways. Because Mahana requires a prescription, your pathway to it necessarily goes through a physician. That is actually a feature, not a bug, because it inserts a clinical conversation before you start. Use that conversation. Ask your physician whether they think CBT-for-IBS or gut-directed hypnotherapy is the better mechanism fit for you specifically, given your symptom pattern and comorbidities. If your physician is not familiar with the distinction, that is information too, and it may suggest that the right next step is a referral to a clinician who is.

When is Mahana NOT the right tool?

I have spent four sections being fair to Mahana on its own terms. Here is the part where I am specific about when it is not the right tool, because an honest review needs to be willing to name the limits.

Do not start with Mahana (or any app) if you have red-flag symptoms. Unexplained weight loss. Blood in stool. Iron-deficiency anemia. New gut symptoms after age 50 with no clear trigger. Family history of colon cancer, IBD, or celiac disease and you have never been screened. Severe night-time symptoms that wake you from sleep. Persistent vomiting. Difficulty swallowing. These need a gastroenterologist workup first. Mahana is for confirmed functional IBS, not for undiagnosed gut symptoms that could be structural disease. Mahana itself would tell you this through the prescribing physician step, which is part of why the prescription gate exists.

Do not pick Mahana if you have already failed two or three self-guided digital interventions. If Nerva did not work for you, and an anxiety CBT app did not finish, and a meditation app sits unopened on your phone, the honest read is that you are unlikely to complete a self-guided 3-month CBT-for-IBS program either. The pattern is the pattern. The right next step in that situation is a human-in-the-loop clinician who will follow up when you skip a week, not another self-guided app.

Do not pick Mahana over a clinician if your situation is complex. Apps deliver fixed protocols. If you have IBS with significant overlap (SIBO, functional dyspepsia, post-infectious IBS, IBD in remission, severe overlapping anxiety, complex trauma history), a clinician who adjusts the protocol session by session usually fits the situation better than any app. Cost is real, complexity is also real, and matching the level of care to the complexity is the honest move.

Do not pick Mahana if the access friction makes it more burden than help. This is the Canadian-specific point. If getting Mahana involves a US-side prescriber, cross-border shipping, possible insurance complications, and time-zone misalignment with support, the burden of accessing the tool may exceed the benefit of using it. The friction has a real cost, including the psychological cost of feeling stuck navigating a system that was not built for you. Nerva or a clinician are both lower-friction starting points for a Canadian reader.

Do not pick Mahana if you specifically want gut-directed hypnotherapy as the mechanism. Mahana is CBT. If you have read the Peters 2016 RCT or the NICE 2022 IBS guideline and decided gut-directed hypnotherapy is the mechanism you want to try, Mahana is not that. Nerva is, and an ARCH-credentialed gut-specialized clinician is. Picking the mechanism deliberately is a reasonable strategy. Picking Mahana when you actually want hypnotherapy because they sound similar is not.

Mahana vs working with a clinician (with my conflict disclosed)

Here is the part where I make the case for clinician-led care, with the conflict openly declared. I run Calgary Gut Hypnotherapy. I am the alternative I am comparing Mahana to. Read accordingly.

Where Mahana beats a clinician like me. Cost, on a per-attempt basis. A 3-month Mahana program in the $250 to $350 USD range is objectively less than a 3-session clinician commitment at $660 to $1,050 CAD, let alone a full protocol at $1,320 to $2,800. Convenience, because the app is on your phone and you do it on your schedule rather than booking a session at a specific time. Consistency, because the protocol is the same one every time and does not depend on whether your clinician had a good week. For mild IBS in a self-directed person who is genuinely going to finish the program, these are real wins.

Where clinician-led care beats Mahana. Personalization, because I adjust the protocol session to session based on what you reported the previous week, and an app delivers the same fixed sequence to everyone. Accountability, because I follow up when you miss a week and that is part of what you are paying for, while an app sends a push notification that you swipe away. Coordination, because I will call your GP, talk to your gastroenterologist, write a letter to your dietitian, or coordinate with your psychologist when the situation calls for it. Mechanism choice, because gut-directed hypnotherapy is what I deliver, and if that is the mechanism you want to try after reading the evidence, an app delivering CBT is not the same thing. Completion rates, because the structural design of capped intake plus session-by-session follow-up produces meaningfully higher completion than self-guided digital therapeutics generally.

Where neither one beats the other, it is just different. Mechanism. CBT-for-IBS and gut-directed hypnotherapy both have real evidence bases and both work for somewhere in the 50% to 70% range of treated patients depending on the study and outcome measure. Neither is clearly superior in head-to-head comparisons in the literature, and choosing between them often comes down to fit (does guided imagery feel comfortable to you?) and prior experience (have you responded to CBT in other contexts?). A thoughtful clinician will discuss this with you rather than insisting their mechanism is the only one that matters.

Insurance honest section. Hypnotherapy isn't directly covered by Canadian provincial health plans or most extended health benefit plans. Hypnotherapy isn't a regulated profession in Alberta. Some clients get reimbursement through their employer's Wellness Spending Account (WSA) under categories like 'stress management' or 'mental wellness'. WSAs are different from Health Spending Accounts (HSAs), which follow strict CRA medical-expense rules that exclude practitioners who aren't on a provincial regulated list. Always check with your specific plan whether RCH services qualify. Mahana itself, being US-based and prescription, has different coverage logic that depends on US insurance pathways and would not typically be reimbursable through a Canadian extended health plan.

Bottom line on Mahana, from a competing clinician. Mahana is a well-built product. The evidence base behind CBT-for-IBS is real. If you are American, motivated, self-directed, and your physician will prescribe it, ask them about it. If you are Canadian, the access friction is the practical barrier that probably routes you to Nerva or a clinician instead. If you specifically want gut-directed hypnotherapy as the mechanism, Mahana is the wrong tool regardless of access, and Nerva or an ARCH-credentialed clinician are the right starting points. None of this is a knock on Mahana. It is just what an honest matching of tool to situation looks like.